Arthur E. H. Bentlage

3.9k total citations
44 papers, 1.3k citations indexed

About

Arthur E. H. Bentlage is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Arthur E. H. Bentlage has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Molecular Biology and 24 papers in Immunology. Recurrent topics in Arthur E. H. Bentlage's work include Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (21 papers) and Blood groups and transfusion (7 papers). Arthur E. H. Bentlage is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (21 papers) and Blood groups and transfusion (7 papers). Arthur E. H. Bentlage collaborates with scholars based in Netherlands, United States and Germany. Arthur E. H. Bentlage's co-authors include Gestur Vidarsson, Theo Rispens, Suzanne N. Lissenberg‐Thunnissen, Gillian Dekkers, Manfred Wuhrer, Wim J.E. van Esch, Juk Yee Mok, Carolien A. M. Koeleman, Remco Visser and James C. Zimring and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Arthur E. H. Bentlage

43 papers receiving 1.3k citations

Peers

Arthur E. H. Bentlage
Anastas Pashov United States
Bonita Rup United States
Vibha Jawa United States
Wim J.E. van Esch Netherlands
M. Brüggemann United Kingdom
Maree S. Powell Australia
Paul Chien United States
Anastas Pashov United States
Arthur E. H. Bentlage
Citations per year, relative to Arthur E. H. Bentlage Arthur E. H. Bentlage (= 1×) peers Anastas Pashov

Countries citing papers authored by Arthur E. H. Bentlage

Since Specialization
Citations

This map shows the geographic impact of Arthur E. H. Bentlage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur E. H. Bentlage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur E. H. Bentlage more than expected).

Fields of papers citing papers by Arthur E. H. Bentlage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur E. H. Bentlage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur E. H. Bentlage. The network helps show where Arthur E. H. Bentlage may publish in the future.

Co-authorship network of co-authors of Arthur E. H. Bentlage

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur E. H. Bentlage. A scholar is included among the top collaborators of Arthur E. H. Bentlage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur E. H. Bentlage. Arthur E. H. Bentlage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bentlage, Arthur E. H., José M. de Pereda, Leendert Porcelijn, et al.. (2025). HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins. Blood. 146(18). 2189–2202.
2.
Damelang, Timon, Arthur E. H. Bentlage, Cornelis W. Tuk, et al.. (2025). Enhancing activity of FcαRI-bispecific antibodies using glycoengineering. The Journal of Immunology. 214(6). 1261–1271. 1 indexed citations
3.
Kissel, Theresa, V. Derksen, Arthur E. H. Bentlage, et al.. (2024). N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line. Nature Communications. 15(1). 393–393. 4 indexed citations
4.
Cleary, Simon J., Nicholas Kwaan, David Bulkley, et al.. (2024). IgG hexamers initiate complement-dependent acute lung injury. Journal of Clinical Investigation. 134(11). 7 indexed citations
5.
Resa‐Infante, Patricia, Itziar Erkizia, Federica Linty, et al.. (2024). Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy. Biomedicine & Pharmacotherapy. 175. 116726–116726. 4 indexed citations
6.
Velden, Saskia van der, Arthur E. H. Bentlage, Juk Yee Mok, et al.. (2023). Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs. Blood. 143(1). 79–91. 19 indexed citations
7.
Volkov, Mikhail, Maximilian Brinkhaus, Karin A. van Schie, et al.. (2023). IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. The Journal of Immunology. 210(2). 158–167. 16 indexed citations
8.
Cruz, Ana Rita, Arthur E. H. Bentlage, Carla J. C. de Haas, et al.. (2022). Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis. The Journal of Immunology. 209(6). 1146–1155. 11 indexed citations
9.
Brinkhaus, Maximilian, Arthur E. H. Bentlage, Ninotska I. L. Derksen, et al.. (2022). The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature Communications. 13(1). 6073–6073. 27 indexed citations
10.
Nouta, Jan, Carolien A. M. Koeleman, Arthur E. H. Bentlage, et al.. (2022). Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages. Platelets. 34(1). 2129604–2129604. 3 indexed citations
11.
Lingg, Nico, Arthur E. H. Bentlage, Natalia Govorukhina, et al.. (2021). Change of charge variant composition of trastuzumab upon stressing at physiological conditions. Journal of Chromatography A. 1655(6). 462506–462506. 15 indexed citations
12.
Braster, Rens, Marijn Bögels, Manfred Wuhrer, et al.. (2021). Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice. Cancers. 13(10). 2372–2372. 7 indexed citations
13.
Heemskerk, Niels, Marieke H. Heineke, Cornelis W. Tuk, et al.. (2021). Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity. Journal of Clinical Investigation. 131(6). 49 indexed citations
14.
Velden, Saskia van der, Arthur E. H. Bentlage, Mads Delbo Larsen, et al.. (2020). Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation. Blood Advances. 4(16). 3875–3885. 11 indexed citations
15.
Brinkhaus, Maximilian, Arthur E. H. Bentlage, Steven W. de Taeye, et al.. (2020). Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function. The Journal of Immunology. 205(12). 3456–3467. 11 indexed citations
16.
Bentlage, Arthur E. H., Steven W. de Taeye, Gerlof P. Bosman, et al.. (2020). Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding. Molecular Immunology. 127. 79–86. 36 indexed citations
17.
Stapleton, Nigel M., Maximilian Brinkhaus, Kathryn L. Armour, et al.. (2019). Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge. Scientific Reports. 9(1). 7363–7363. 26 indexed citations
18.
Dekkers, Gillian, Fleur S. van de Bovenkamp, Arthur E. H. Bentlage, et al.. (2019). Human DC-SIGN and CD23 do not interact with human IgG. Scientific Reports. 9(1). 9995–9995. 38 indexed citations
19.
Bruggeman, Christine W., Gillian Dekkers, Arthur E. H. Bentlage, et al.. (2017). Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile. The Journal of Immunology. 199(1). 204–211. 64 indexed citations
20.
Schaardenburg, Dirkjan van, Pleuni Ooijevaar‐de Heer, Michel Tsang-A-Sjoe, et al.. (2016). Anti-Hinge Antibodies Recognize IgG Subclass– and Protease-Restricted Neoepitopes. The Journal of Immunology. 198(1). 82–93. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026